TNF alpha (TNF) Human shRNA Plasmid Kit (Locus ID 7124)
CAT#: TG318768
TNF - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
TNF mouse monoclonal antibody, clone OTI1C1 (formerly 1C1)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | TNF alpha (TNF) Human shRNA Plasmid Kit (Locus ID 7124) |
Locus ID | 7124 |
UniProt ID | P01375 |
Synonyms | DIF; TNF-alpha; TNFA; TNFSF2; TNLG1F |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | TNF - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 7124). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_000594, NM_000594.1, NM_000594.2, NM_000594.3, BC028148, BC028148.1, NM_000594.4 |
Summary | This gene encodes a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. This cytokine is mainly secreted by macrophages. It can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. This cytokine is involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. This cytokine has been implicated in a variety of diseases, including autoimmune diseases, insulin resistance, psoriasis, rheumatoid arthritis ankylosing spondylitis, tuberculosis, autosomal dominant polycystic kidney disease, and cancer. Mutations in this gene affect susceptibility to cerebral malaria, septic shock, and Alzheimer disease. Knockout studies in mice also suggested the neuroprotective function of this cytokine. [provided by RefSeq, Aug 2020] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells
,Zhang, Z;Lin, G;Yan, Y;Li, X;Hu, Y;Wang, J;Yin, B;Wu, Y;Li, Z;Yang, XP;,
Oncogene
,PubMed ID 29559745
[TNF]
|
Targeting Transmembrane TNF-a Suppresses Breast Cancer Growth
,Mingxia Yu, Xiaoxi Zhou, Lin Niu, Guohong Lin, Jin Huang, Wenjing Zhou, Hui Gan, Jing Wang, Xiaodan Jiang, Bingjiao Yin, and Zhuoya Li,
Cancer Res., Jul 2013; 73: 4061 - 4074.
,PubMed ID 23794706
[TNF]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...